NuView Molecular Pharmaceuticals, Inc., NuView Life Sciences, Inc., and Paul Crowe v. John Bisnar, in His Capacity as Trustee for JPB IK Plan, Assignee of Interstate Restoration, LLC, and Individually
This text of NuView Molecular Pharmaceuticals, Inc., NuView Life Sciences, Inc., and Paul Crowe v. John Bisnar, in His Capacity as Trustee for JPB IK Plan, Assignee of Interstate Restoration, LLC, and Individually (NuView Molecular Pharmaceuticals, Inc., NuView Life Sciences, Inc., and Paul Crowe v. John Bisnar, in His Capacity as Trustee for JPB IK Plan, Assignee of Interstate Restoration, LLC, and Individually) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
In the Court of Appeals Second Appellate District of Texas at Fort Worth ___________________________
No. 02-21-00055-CV ___________________________
NUVIEW MOLECULAR PHARMACEUTICALS, INC., NUVIEW LIFE SCIENCES, INC., AND PAUL CROWE, Appellants
V.
JOHN BISNAR, IN HIS CAPACITY AS TRUSTEE FOR JPB IK PLAN, ASSIGNEE OF INTERSTATE RESTORATION, LLC, AND INDIVIDUALLY, Appellee
On Appeal from the 158th District Court Denton County, Texas Trial Court No. 20-8901-158
Before Walker, J.; Sudderth, C.J.; and Kerr, J. Per Curiam Memorandum Opinion MEMORANDUM OPINION AND JUDGMENT
We have considered “Appellants’ Unopposed Motion to Dismiss Appeal.” We
grant the motion and dismiss the appeal. See Tex. R. App. P. 42.1(a)(1), 43.2(f).
Each party must bear its own costs of appeal. See Tex. R. App. P. 42.1(d), 43.4.
Per Curiam
Delivered: April 6, 2023
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
NuView Molecular Pharmaceuticals, Inc., NuView Life Sciences, Inc., and Paul Crowe v. John Bisnar, in His Capacity as Trustee for JPB IK Plan, Assignee of Interstate Restoration, LLC, and Individually, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nuview-molecular-pharmaceuticals-inc-nuview-life-sciences-inc-and-texapp-2023.